Standard and Interpretation
The standardized diagnosis and treatment of rheumatoid arthritis
Geng Yan, Xie Xi, Wang Yu, Jiang Dexun, Zhang Wen, Zhang Zhuoli, Zhao Yan, on behalf of Chinese Rheumatololgy Association
Published 2022-01-01
Cite as Chin J Intern Med, 2022, 61(1): 51-59. DOI: 10.3760/cma.j.cn112138-20210616-00426
Abstract
Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation of the joints with high risk of disability. In recent years, remarkable progress has been made towards the diagnosis and treatment of RA, and the international RA guidelines have been also kept updated. Nevertheless, there are many challenges in China, especially inadequate number of rheumatologists and insufficient experience in the diagnosis and treatment of RA. Therefore, Chinese Rheumatology Association drafted the standardized diagnosis and treatment of RA based on the available evidence, so as to improve the management of RA patients in China.
Key words:
Arthritis, rheumatoid; Diagnosis; Treatment; Benchmarking
Contributor Information
Geng Yan
Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing 100034, China
Xie Xi
Department of Rheumatology and Clinical Immunology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
Wang Yu
Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing 100034, China
Jiang Dexun
Department of Rheumatology and Immunology, Seventh Medical Center of Chinese PLA General Hospital, Beijing 100700, China
Zhang Wen
Department of Rheumatology and Clinical Immunology, Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &
Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
Zhang Zhuoli
Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing 100034, China
Zhao Yan
Department of Rheumatology and Clinical Immunology, Peking Union Medical College, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &
Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
on behalf of Chinese Rheumatololgy Association
